🇺🇸 FDA
Patent

US 8216614

Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis

granted A61KA61K31/19A61K33/08

Quick answer

US patent 8216614 (Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis) held by The Board of Regents of the University of Texas System expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/19, A61K33/08, A61K33/10, A61P